Company Fundamentals\Company Profile
A Wright Investors' Service Research Report:
Beijing SL Pharmaceutical Co., Ltd.
440 Wheelers Farms Road
Milford, CT 06461 U.S.A.
Figures in Chinese Renmimbi
Wright Quality Rating:BAA20 Key Data
Beijing SL Pharmaceutical Co., Ltd. is principally engaged in the development, Ticker:
production and sale of gene engineering drugs. The Company provides four 002038
categories of products: biological products, including rhG-CSF injections, interleukin-
2 injections, rhIL-11 injections and rh-bFGF; biochemicals, such as cytidine disodium 2010 Sales:
triphosphate for injection, calcium folinate for injection, salmon calcitonin injection,
coenzyme complex for injection, netilmicin sulfate injection, matrine injection and
ciclosporin injection; tablets and capsules, including desloratadine orally-
disintegrating tablets, zaleplon capsules, naftopidil tablets, tropisetron hydrochloride Major Industry:
capsules, telmisartan tablets, metformin hydrochloride and glyburide tablets and Drugs, Cosmetics & Health
stavudine capsules, and health-care food, including Hongxin Capsule. It distributes Care
its products in domestic and overseas markets.
Stock Chart Officers Sub Industry:
Chairman & General Ethical Drug Manufacturers
Mingbo Xu Country:
Chief Financial Officer
Wenying Xi Currency:
Fiscal Year Ends: